跳至主要内容
临床试验/KCT0003829
KCT0003829尚未招募未知

A prospective randomized study of the usfulness of the artery first approach in pancreatic cancer with pancreaticoduodenectomy

Asan Medical Center0 个研究点目标入组 268 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
268

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 79(Year)(—)
性别
All

入选标准

  • 1. The patients who need to undergo pancreatoduodnectomy for pancreatic head cancer
  • 2. No systemic metastasis
  • 3. more than 20 years old
  • 4. Patients who can read and understand the informed consent and can express their intent to agree

排除标准

  • 1. Systemic metastasis
  • 2. Neoadjuvant chemothearpy for borderline resectable pancreatic cancer or locally advanced pancreatic cancer
  • 3.. patients who need reconstruct artery
  • 4. Ischemic heart disease
  • 5. Severe liver failure, liver cirrhosis
  • 6. Respiratory distress with oxygen therapy
  • 7. Chronic kidney disease with hemodialysis
  • 8. severe psychological or neurological disease
  • 9. Drug abuse, alcoholism

研究者

相似试验